Forest overtook Pfizer as the top professional advertiser in the first half of 2011, boosting spend 15.3% over the same period last year to $24.1 million. Pfizer, perennially among the top three advertisers in journals, slashed print allocation by more than half to $10.3 million, falling to number four. Eli Lilly ramped up outlays 115.9%, landing at number 2.
New faces among the Top 10 include Takeda, thanks to a 98% gain, and Abbott, which hiked ad spend 256.1%.
Click sobre imagen para ampliar
(Ver)
Ver también:
Entradas
No hay comentarios:
Publicar un comentario